MTX and Steroid as First-line Therapy for aGVHD

Clinical trial NCT04960644 · COMPLETED

Trial details

NCT number: NCT04960644
Sponsor: Peking University People's Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute GVH Disease

Start date: 2021-06-25
Primary completion: 2022-07-31
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.